berberine has been researched along with transforming growth factor beta in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Y; Qiu, QY; Wang, P; Wu, J | 1 |
| Dai, DZ; Dai, Y; Du, RH; Tang, WH; Yi, HW | 1 |
| Chitra, P; Manikandan, R; Saiprasad, G; Sudhandiran, G | 1 |
| Fan, LH; Ji, XX; Qi, HW; Xin, LY; Xu, X | 1 |
| Bilal, MU; Chen, X; Cheng, F; Du, N; Ju, J; Li, J; Li, X; Liu, X; Lu, Y; Wei, Y; Xu, C; Yang, B; Yang, L; Zhang, Q; Zhang, Y | 1 |
| Agrawal-Rajput, R; Gaikwad, S; Naveen, CR | 1 |
| Chi, ZH; He, H; Jiang, Y; Liang, D; Liang, W; Ma, J; Zhang, X | 1 |
| Li, Z; Zhang, W | 1 |
| Chen, L; Cheng, Z; Guo, J; Liu, L; Luo, N; Xie, Y | 1 |
| Deng, H; Liu, L; Liu, X; Liu, Y; Song, D; Wang, Y; Yin, M; Zeng, Q; Zhang, N | 1 |
| Huang, C; Pang, Z; Tao, L; Wang, XL | 1 |
| Chen, M; Chen, S; Gu, Y; Liu, P; Shen, H; Yang, H; Ye, P; Zhu, L | 1 |
| Deng, J; Gong, X; Huang, J; Lai, Z; Li, C; Li, X; Liu, Y; Xiao, Y; Ye, X; Zhang, Y | 1 |
| Deng, J; Gong, X; Gui, Z; Huang, J; Li, C; Li, X; Liu, Y; Xiao, Y; Ye, X; Zhang, Y | 1 |
| Sheng, J; Shi, B; Sun, X; Wang, L; Wang, X; Wang, Z; Xie, Y; Yang, H; Zi, C | 1 |
| Chen, X; Diao, J; Ma, X; Mou, P; Wei, R | 1 |
| Chen, Y; Chen, Z; Dong, X; Du, M; Han, J; Han, W; Li, X; Lin, Y; Liu, H; Liu, X; Sun, H; Sun, X; Tang, P; Xu, H; Xu, R; Zhang, Y; Zhao, L | 1 |
17 other study(ies) available for berberine and transforming growth factor beta
| Article | Year |
|---|---|
[Effects of ginsenoside and berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG].
Topics: Apoptosis; Berberine; Coculture Techniques; Dinoprostone; Ginsenosides; Humans; Jurkat Cells; Lung Neoplasms; Transforming Growth Factor beta; Tumor Cells, Cultured | 2008 |
Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Aspartic Acid Endopeptidases; Berberine; Cardiomegaly; Cardiomyopathies; Disease Models, Animal; Endothelin-1; Endothelin-Converting Enzymes; Ether-A-Go-Go Potassium Channels; Inflammation Mediators; Male; Metalloendopeptidases; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Propranolol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thyroxine; Transforming Growth Factor beta; Up-Regulation; Ventricular Fibrillation | 2008 |
Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
Topics: Animals; Antimetabolites; Berberine; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Collagen; Histamine Release; Hydroxyproline; Immunohistochemistry; Lung Diseases; Male; Malondialdehyde; Microscopy, Confocal; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; Peroxidase; Pulmonary Fibrosis; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis.
Topics: Animals; Apoptosis; Berberine; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Transcription Factors; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays | 2014 |
Berberine hydrochloride prevents postsurgery intestinal adhesion and inflammation in rats.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Disease Models, Animal; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Intestinal Diseases; Male; Molecular Structure; Postoperative Complications; Rats; Rats, Sprague-Dawley; Tissue Adhesions; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2014 |
Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Mice; Neoplastic Stem Cells; Neuroblastoma; Neurons; Signal Transduction; Transforming Growth Factor beta | 2016 |
Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice.
Topics: Animals; Berberine; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Kidney; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Streptozocin; Transforming Growth Factor beta | 2016 |
Protective effect of berberine on renal fibrosis caused by diabetic nephropathy.
Topics: Actins; Animals; Berberine; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Fibrosis; Kidney; Male; NF-kappa B; Protective Agents; Rats; Rats, Wistar; Streptozocin; Transforming Growth Factor beta; Vimentin | 2017 |
Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: Imply the possible treatment of adenomyosis.
Topics: Adenomyosis; Adult; Apoptosis; Berberine; Cell Cycle; Cell Proliferation; Cells, Cultured; Endometrium; Epidermal Growth Factor; Female; Humans; Interleukin-6; Interleukin-8; NF-kappa B; Phenotype; STAT3 Transcription Factor; Stromal Cells; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Young Adult | 2018 |
MPB, a novel berberine derivative, enhances lysosomal and bactericidal properties via TGF-β-activated kinase 1-dependent activation of the transcription factor EB.
Topics: Adaptor Proteins, Signal Transducing; Adenylate Kinase; Animals; Anti-Bacterial Agents; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Berberine; Cell Nucleus; Cells, Cultured; Humans; Lysosomes; Macrophages; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; Mice; Phosphorylation; Protein Transport; Signal Transduction; TOR Serine-Threonine Kinases; Transforming Growth Factor beta | 2019 |
Berberine reversed the epithelial-mesenchymal transition of normal colonic epithelial cells induced by SW480 cells through regulating the important components in the TGF-β pathway.
Topics: Berberine; Biomarkers; Cell Line, Tumor; Cell Movement; Colon; Culture Media, Conditioned; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Phenotype; Phosphorylation; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Wound Healing | 2019 |
Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
Topics: Animals; Berberine; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Hypoxia; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Vascular Remodeling; Ventricular Function, Right | 2019 |
An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Topics: Alkaloids; Animals; Berberine; Computational Biology; Diabetic Nephropathies; Drugs, Chinese Herbal; Gene Expression Regulation; Glycation End Products, Advanced; Lipids; Male; Mice; Phosphatidylinositol 3-Kinases; Protein Interaction Maps; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Signal Transduction; Smad2 Protein; Transcriptome; Transforming Growth Factor beta | 2021 |
Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway.
Topics: Angiotensinogen; Animals; Berberine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Gene Expression Regulation; Kidney; Male; Mesangial Cells; Mice, Obese; Molecular Docking Simulation; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2021 |
Demethyleneberberine promotes apoptosis and suppresses TGF-β/Smads induced EMT in the colon cancer cells HCT-116.
Topics: Antineoplastic Agents; Apoptosis; Berberine; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; HCT116 Cells; Humans; Molecular Structure; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Tumor Cells, Cultured | 2021 |
Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
Topics: Berberine; Fibroblasts; Fibrosis; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Inflammation; Orbit; Transforming Growth Factor beta | 2022 |
Tetrahydroberberrubine prevents peritoneal adhesion by suppressing inflammation and extracellular matrix accumulation.
Topics: Animals; Berberine; Extracellular Matrix; Inflammation; Intercellular Adhesion Molecule-1; NF-kappa B; Rats; Transforming Growth Factor beta | 2023 |